Staying safe from hepatitis C: Engaging with multiple priorities

Qualitative Health Research

Volumn 22, Issue 1, 2012, Pages 31-42

  Harris, Magdalena ^a   Treloar, Carla ^b   Maher, Lisa ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

addiction substance use; hepatitis C; illness and disease; life history; prevention; risk, behaviors

Indexed keywords

ADULT; ARTICLE; BODY WEIGHT; DIET; DISEASE TRANSMISSION; DRUG ABUSE; ENVIRONMENT; FAMILY; FEMALE; HEALTH CARE POLICY; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; INTERVIEW; MALE; MOTIVATION; PSYCHOLOGICAL ASPECT; SOCIAL ENVIRONMENT; SOCIAL SUPPORT; STATISTICS; SUBSTANCE ABUSE;

ADULT; BODY WEIGHT; DIET; ENVIRONMENT; FAMILY; FEMALE; HEALTH POLICY; HEPATITIS C; HUMANS; INTERVIEWS AS TOPIC; MALE; MOTIVATION; NEEDLE SHARING; RISK-TAKING; SOCIAL ENVIRONMENT; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 83455205616     PISSN: 10497323     EISSN: 15527557     Source Type: Journal    
DOI: 10.1177/1049732311420579     Document Type: Article

References (52)

1. Australian Injecting and Illicit Drug Users League. (2010). Legislative and policy barriers to needle & syringe programs and injecting equipment access for people who inject drugs. Canberra, Australia: Author. Retrieved from http://www.aivl.org.au/files/29057-AIVL-book-text-FA.pdf
2. Blackwell J. S.. Drifting, controlling and overcoming: Opiate users who avoid becoming chronically dependent. Journal of Drug Issues. 1983 ; 13: 219-235 (Pubitemid 13002974)
3. BoeriM. W. (2004). "Hell, I'm an addict, but I ain't no junkie": An ethnographic analysis of aging heroin users. Human Organization, 63, 236-245. Retrieved from http://works.bepress.com/miriam-boeri/ 9/
4. Bourgois P., Prince B., Moss A.. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Human Organization. 2004 ; 63: 253-264 (Pubitemid 39437329)
5. Cohen P., Sas A.. Cocaine use in Amsterdam in non-deviant subcultures. Addiction Research. 1994 ; 2: 71-94
6. Fraser S.. "It's your life!": Injecting drug users, individual responsibility and hepatitis C prevention. Health. 2004 ; 8: 199-221 (Pubitemid 38392438)
7. Fraser S., Treloar C.. 'Spoiled identity' in hepatitis C infection: The binary logic of despair. Critical Public Health. 2006 ; 16: 99-110 (Pubitemid 44659282)
8. Friedman S., Mateu-Gelabert P., Sandoval M., Hagan H., Des Jarlais D.. Positive deviance control-case life history: A method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health 8. 2008 ;: 1-10
9. Glaser B., Strauss A. Discovery of grounded theory: Strategies for qualitative research. Chicago: Aldine de Gruyter ; 1967:
10. Goffman E. Stigma: Notes on the management of a spoiled identity. Middlesex, UK: Penguin ; 1963:
11. Grund J. P., Friedman S., Stern L., Jose B., Neaigus A., Curtis R., Des Jarlais D.. Syringe-mediated sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens. Social Science and Medicine. 1996 ; 42: 691-703 (Pubitemid 26067875)
12. Hagan H., Campbell J., Thiede H., Strathdee S., Ouellet L., Latka M., Garfein R.. Injecting alone among young adult IDUs in five US cities: Evidence of low rates of injection risk behavior. Drug and Alcohol Dependence. 2007 ; 91: S48 - S55
13. Hagan H., Pouget E. R., Williams I. T., Garfein R. L., Strathdee S. A., Hudson S. M., Ouelley L. J.. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. Journal of Infectious Diseases. 2010 ; 201: 378-385
14. Harris M.. Living with hepatitis C: The medical encounter. New Zealand Sociology. 2005 ; 20: 4-19
15. Harris M.. Injecting, infection, illness: Abjection and hepatitis C stigma. Body & Society. 2009 ; 15 (4). 33-51
16. Harris M.. Pleasure and guilt: Alcohol use and hepatitis C. Qualitative Health Research. 2010 ; 20: 1262-1271
17. Health Protection Agency. (2009). Hepatitis C in the UK 2009. London: Health Protection Agency Centre for Infections. Retrieved from http://www.hpa.org.uk/Publications/InfectiousDiseases/BloodBorneInfections/ 0912HepatitisC/
18. Heckathorn D.. Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems 44. 1997 ;: 174-199
19. Heimer R., Clair S., Grau L. E., Bluthenthal R. N., Marshall P. A., Singer M.. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction. 2002 ; 97: 1277-1287
20. HubbardG. (2000). The usefulness of in-depth life history interviews for exploring the role of social structure and human agency in youth transitions. Sociological Research Online, 4. Retrieved from http://ideas.repec.org/a/sro/ srosro/1999-84-3.html
21. Hunt D. E.. A selected bibliography on the drug use(r) "career.". Substance Use & Misuse. 1997 ; 32: 283-291 (Pubitemid 127747931)
22. Jackson L., Parker J., Dykeman M., Gahagan J., Karabanow J.. The power of relationships: Implications for safer and unsafe practices among injection drug users. Drugs: Education, Prevention and Policy. 2010 ; 17: 189-204
23. Kim D., Irwin K., Khoshnood K.. Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. American Journal of Public Health. 2009 ; 99: 402-407
24. LappingK.MarshD. R.RosenbaumJ.SwedbergE.SterninJ.SterninM.SchoederD. G. (2002). The positive deviance approach: Challenges and opportunities for the future. Food and Nutrition Bulletin, 23, 130-137. Retrieved from www.ncbi.nlm.nih.gov/pubmed/12503241 (Pubitemid 36036567)
25. Lavanchy D.. Chronic viral hepatitis as a public health issue in the world. Best Practice & Research Clinical Gastroenterology. 2008 ; 22: 991-1008
26. LentonS.DietzeP.DarkeL.ButlerT. (2009). Naloxone for administration by peers in cases of heroin overdose. Medical Journal Australia, 191, 469. Retrieved from http://www.mja.com.au/public/issues/191-08-191009/letters-191009- fm-1.html
27. Maher L.. Don't leave us this way: Ethnography and injecting drug use in the age of AIDS. International Journal of Drug Policy. 2002 ; 13: 311-325 (Pubitemid 35284592)
28. Maher L., Li J., Jalaludin B., Chant K., Kaldor J.. High hepatitis C incidence in new injecting drug users: A policy failure?. Australian New Zealand Journal of Public Health. 2007 ; 31: 30-35 (Pubitemid 46380631)
29. Maher L., White B., Hellard M., Madden A., Prins M., Kerr T., Page K.. Candidate hepatitis C vaccine trials and people who inject drugs: Challenges and opportunities. Vaccine. 2010 ; 28: 7273-7278
30. Mateu-Gelabert P., Sandoval M., Meylakhs P., Wendel T., Friedman S. R.. Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks. International Journal of Drug Policy. 2010 ; 21: 179-185
31. Mateu-Gelabert P., Treloar C., Calatayud V. A., Sandoval M., Zurián J. C., Maher L., Friedman S. R.. How can hepatitis C be prevented in the long term?. International Journal of Drug Policy. 2007 ; 18: 338-340 (Pubitemid 47374509)
32. Miller P. G.. Safe using messages may not be enough to promote behavior change amongst injecting drug users who are ambivalent or indifferent towards death. Harm Reduction Journal. 2009 ; 6 (18). 1-8
33. Moore D.. Governing street-based injecting drug users: A critique of heroin overdose prevention in Australia. Social Science & Medicine. 2004 ; 59: 1547-1557 (Pubitemid 38891420)
34. National Centre in HIV Epidemiology and Clinical Research. (2008). Australian NSP survey national data report 2003-2007. Sydney, NSW, Australia: Author, The University of New South Wales. Retrieved from http://www.med.unsw. edu.au/nchecrweb.nsf/resources/NSP-Complete2/$file/ANSP.NDR.2003-2007.pdf
35. National Centre in HIV Epidemiology and Clinical Research. (2009). Australian NSP survey national data report 2004-2008. Sydney, NSW, Australia: Author, The University of New South Wales. Retrieved from http://www.med.unsw. edu.au/NCHECRweb.nsf/resources/NSP-Complete/$file/NSP-Survey-04-08.pdf
36. Page K., Hahn J. A., Evans J., Shiboski S., Lum P., Delwart E., Busch M. P.. Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection. Journal of Infectious Diseases. 2009 ; 200: 1216-1226
37. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., Goldberg D.. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews. Addiction. 2010 ; 105: 844-859
38. Radcliffe P., Stevens A.. Are drug treatment services only for 'thieving junkie scumbags'? Drug users and the management of stigmatized identities. Social Science and Medicine. 2008 ; 67: 1065-1073
39. Rhodes T.. The 'risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy. 2002 ; 13: 85-94 (Pubitemid 34607323)
40. Rhodes T., Davis M., Judd A.. Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction. 2004 ; 99: 621-633 (Pubitemid 38561426)
41. Rhodes T., Kimber J., Small W., Fitzgerald J., Kerr T., Hickman M., Holloway G.. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction. 2006 ; 101: 1384-1393 (Pubitemid 44337759)
42. Rhodes T., Watts L., Davies S., Martin A., Smith J., Clark D., Lyons M.. Risk, shame and the public injector: A qualitative study of drug injecting in South Wales. Social Science & Medicine. 2007 ; 65: 572-585 (Pubitemid 47017521)
43. Stuckey H. L., Boan J., Kraschnewski J. L., Miller-Day M., Lehman E. B., Sciamanna C. N.. Using positive deviance for determining successful weight-control practices. Qualitative Health Research. 2010 ; 20: 563-579
44. Thomas D. L., Astemborski J., Rai R. M., Anania F. A., Schaeffer M., Galai N., Vlahov D.. The natural history of hepatitis C virus infection: Host, viral, and environmental factors. JAMA 284. 2000 ;: 450-456 (Pubitemid 30484478)
45. Timeline Maker Professional. (2009). (Version 2.1.6.2) [Computer software]. Nova Scotia, Canada: Progeny Software. Retrieved from www.timelinemaker.com
46. Treloar C., Abelson J.. Information exchange among injecting drug users: A role for an expanded peer education workforce. International Journal of Drug Policy. 2005 ; 16: 46-53 (Pubitemid 40128241)
47. Treloar C., Fraser S.. Hepatitis C, blood and models of the body: New directions for public health. Critical Public Health. 2004 ; 14: 377-389 (Pubitemid 40514744)
48. Treloar C., Laybutt B., Jauncey M., van Beek I., Lodge M., Malpas G., Carruthers S.. Broadening discussions of "safe" in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice. International Journal of Drug Policy. 2008 ; 19: 59-65 (Pubitemid 351200020)
49. Treloar C., Rhodes T.. The lived experience of hepatitis C and its treatment among injecting drug users: Qualitative synthesis. Qualitative Health Research. 2009 ; 19: 1321-1334
50. Vickerman P., Hickman M., Judd A.. Modelling the impact on hepatitis C transmission of reducing syringe sharing: London case study. International Journal of Epidemiology. 2007 ; 36: 396-405 (Pubitemid 47062861)
51. Walker L., Sterling B., Hoke M., Dearden K.. Applying the concept of positive deviance to public health data: A tool for reducing health disparities. Public Health Nursing. 2007 ; 24: 571-576
52. Zinberg N. E. Drug, set and setting. New Haven, CT: Yale University Press ; 1984: